Cargando…
Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis
Heterotopic ossification (HO) is a frequent complication after total hip arthroplasty (THA). Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used as routine prophylaxis for HO after THA. However, the efficacy of NSAIDs on HO, particularly selective NSAIDs versus nonselective NSAIDs, is uncer...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602535/ https://www.ncbi.nlm.nih.gov/pubmed/25950691 http://dx.doi.org/10.1097/MD.0000000000000828 |
_version_ | 1782394740057047040 |
---|---|
author | Kan, Shun-Li Yang, Bo Ning, Guang-Zhi Chen, Ling-Xiao Li, Yu-Lin Gao, Shi-Jie Chen, Xing-Yu Sun, Jing-Cheng Feng, Shi-Qing |
author_facet | Kan, Shun-Li Yang, Bo Ning, Guang-Zhi Chen, Ling-Xiao Li, Yu-Lin Gao, Shi-Jie Chen, Xing-Yu Sun, Jing-Cheng Feng, Shi-Qing |
author_sort | Kan, Shun-Li |
collection | PubMed |
description | Heterotopic ossification (HO) is a frequent complication after total hip arthroplasty (THA). Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used as routine prophylaxis for HO after THA. However, the efficacy of NSAIDs on HO, particularly selective NSAIDs versus nonselective NSAIDs, is uncertain. We searched PubMed, Embase, the Cochrane Central Register of Controlled Trials, and clinicaltrials.gov to identify randomized controlled trials with respect to HO after THA. Two reviewers extracted the data and estimated the risk of bias. For the ordered data, we followed the Bayesian framework to calculate the odds ratio (OR) with a 95% credible interval (CrI). For the dichotomous data, the OR and 95% confidence interval (CI) were calculated using Stata version 12.0. The subgroup analyses and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach were used. A total of 1856 articles were identified, and 21 studies (5995 patients) were included. In the NSAIDs versus placebo analysis, NSAIDs could decrease the incidence of HO, according to the Brooker scale (OR = 2.786, 95% CrI 1.879–3.993) and Delee scale (OR = 9.987, 95% CrI 5.592–16.17). In the selective NSAIDs versus nonselective NSAIDs analysis, there was no significant difference (OR = 0.7989, 95% CrI 0.5506–1.125) in the prevention of HO. NSAIDs could increase discontinuation caused by gastrointestinal side effects (DGSE) (OR = 1.28, 95% CI 1.00–1.63, P = 0.046) more than a placebo. Selective NSAIDs could decrease DGSE (OR = 0.48, 95% CI 0.24–0.97, P = 0.042) compared with the nonselective NSAIDs. There was no significant difference with respect to discontinuation caused by nongastrointestinal side effects (DNGSE) in NSAIDs versus a placebo (OR = 1.16, 95% CI 0.88–1.53, P = 0.297) and in selective NSAIDs versus nonselective NSAIDs (OR = 0.83, 95% CI 0.50–1.37, P = 0.462). NSAIDs might reduce the incidence of HO and increase DGSE in the short-term. |
format | Online Article Text |
id | pubmed-4602535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-46025352015-10-27 Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis Kan, Shun-Li Yang, Bo Ning, Guang-Zhi Chen, Ling-Xiao Li, Yu-Lin Gao, Shi-Jie Chen, Xing-Yu Sun, Jing-Cheng Feng, Shi-Qing Medicine (Baltimore) 7100 Heterotopic ossification (HO) is a frequent complication after total hip arthroplasty (THA). Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used as routine prophylaxis for HO after THA. However, the efficacy of NSAIDs on HO, particularly selective NSAIDs versus nonselective NSAIDs, is uncertain. We searched PubMed, Embase, the Cochrane Central Register of Controlled Trials, and clinicaltrials.gov to identify randomized controlled trials with respect to HO after THA. Two reviewers extracted the data and estimated the risk of bias. For the ordered data, we followed the Bayesian framework to calculate the odds ratio (OR) with a 95% credible interval (CrI). For the dichotomous data, the OR and 95% confidence interval (CI) were calculated using Stata version 12.0. The subgroup analyses and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach were used. A total of 1856 articles were identified, and 21 studies (5995 patients) were included. In the NSAIDs versus placebo analysis, NSAIDs could decrease the incidence of HO, according to the Brooker scale (OR = 2.786, 95% CrI 1.879–3.993) and Delee scale (OR = 9.987, 95% CrI 5.592–16.17). In the selective NSAIDs versus nonselective NSAIDs analysis, there was no significant difference (OR = 0.7989, 95% CrI 0.5506–1.125) in the prevention of HO. NSAIDs could increase discontinuation caused by gastrointestinal side effects (DGSE) (OR = 1.28, 95% CI 1.00–1.63, P = 0.046) more than a placebo. Selective NSAIDs could decrease DGSE (OR = 0.48, 95% CI 0.24–0.97, P = 0.042) compared with the nonselective NSAIDs. There was no significant difference with respect to discontinuation caused by nongastrointestinal side effects (DNGSE) in NSAIDs versus a placebo (OR = 1.16, 95% CI 0.88–1.53, P = 0.297) and in selective NSAIDs versus nonselective NSAIDs (OR = 0.83, 95% CI 0.50–1.37, P = 0.462). NSAIDs might reduce the incidence of HO and increase DGSE in the short-term. Wolters Kluwer Health 2015-05-08 /pmc/articles/PMC4602535/ /pubmed/25950691 http://dx.doi.org/10.1097/MD.0000000000000828 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 7100 Kan, Shun-Li Yang, Bo Ning, Guang-Zhi Chen, Ling-Xiao Li, Yu-Lin Gao, Shi-Jie Chen, Xing-Yu Sun, Jing-Cheng Feng, Shi-Qing Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis |
title | Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis |
title_full | Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis |
title_fullStr | Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis |
title_short | Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis |
title_sort | nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after total hip arthroplasty: a systematic review and meta-analysis |
topic | 7100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602535/ https://www.ncbi.nlm.nih.gov/pubmed/25950691 http://dx.doi.org/10.1097/MD.0000000000000828 |
work_keys_str_mv | AT kanshunli nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT yangbo nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT ningguangzhi nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT chenlingxiao nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT liyulin nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT gaoshijie nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT chenxingyu nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT sunjingcheng nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis AT fengshiqing nonsteroidalantiinflammatorydrugsasprophylaxisforheterotopicossificationaftertotalhiparthroplastyasystematicreviewandmetaanalysis |